ACP J Club. 2006 Nov-Dec;145(3):66.

Review: selective COX-2 inhibitors increase vascular events more than placebo and naproxen, but not more than other NSAIDs.

Laupacis A.

Source

Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.

Comment on

BMJ. 2006 Jun 3;332(7553):1302-8.

PMID:: 17080978; [PubMed]

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs. [Evid Based Med. 2006]
Review: Selective COX 2 inhibitors increase vascular events more than placebo and naproxen but not more than other NSAIDs.
Laupacis A. Evid Based Med. 2006 Dec; 11(6):171.
Review Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. [Health Technol Assess. 2008]
Review Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS. Health Technol Assess. 2008 Apr; 12(11):1-278, iii.
Review Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man. [J Physiol Pharmacol. 2008]
Review Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ, Islam K. J Physiol Pharmacol. 2008 Aug; 59 Suppl 2:117-33.
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib. [Curr Med Res Opin. 2006]
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxib.
Curtis SP, Ko AT, Bolognese JA, Cavanaugh PF, Reicin AS. Curr Med Res Opin. 2006 Dec; 22(12):2365-74.
Review Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. [Anesth Analg. 2007]
Review Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
Joshi GP, Gertler R, Fricker R. Anesth Analg. 2007 Dec; 105(6):1793-804, table of contents.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Review: selective COX-2 inhibitors increase vascular events more than placebo an...
Review: selective COX-2 inhibitors increase vascular events more than placebo and naproxen, but not more than other NSAIDs.
ACP J Club. 2006 Nov-Dec ;145(3):66.

PubMed
Systematic review of systematic reviews of acupuncture.
Systematic review of systematic reviews of acupuncture.
Clin Med. 2006 Sep-Oct ;6(5):508-9.

PubMed
Hypovolemia and dehydration in the oncology patient.
Hypovolemia and dehydration in the oncology patient.
J Support Oncol. 2006 Oct ;4(9):447-54; discussion 455-7.

PubMed
Tachykinin receptors mediating airway macromolecular secretion.
Tachykinin receptors mediating airway macromolecular secretion.
Life Sci. 1991 ;48(17):1609-18.

PubMed
The resistance to changing guidelines--what are the challenges and how to meet t...
The resistance to changing guidelines--what are the challenges and how to meet them.
Best Pract Res Clin Anaesthesiol. 2006 Sep ;20(3):379-95.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Review: selective COX-2 inhibitors increase vascular events more than placebo and naproxen, but not more than other NSAIDs.

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information